Your browser doesn't support javascript.
loading
Outcome of Husband-to-Wife Kidney Transplantation With Mutual Children: Single Center Experience Using T Cell-Depleting Induction and Review of the Literature.
Senn, Lisa; Wehmeier, Caroline; Hönger, Gideon; Geiger, Irene; Amico, Patrizia; Hirt-Minkowski, Patricia; Steiger, Jürg; Dickenmann, Michael; Schaub, Stefan.
Afiliação
  • Senn L; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Wehmeier C; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Hönger G; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Geiger I; HLA-Diagnostics and Immungenetics, Department of Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
  • Amico P; Transplantation Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Hirt-Minkowski P; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Steiger J; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Dickenmann M; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
  • Schaub S; Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.
Front Med (Lausanne) ; 8: 724851, 2021.
Article em En | MEDLINE | ID: mdl-34409057
ABSTRACT
Few data on husband-to-wife transplantations with mutual children (H2W) exist in the current era. We investigated the outcome of H2W transplantations (n = 25) treated with T cell-depleting induction compared to women with prior pregnancies also receiving their first HLA-mismatched kidney transplant, but from a different donor source (i) other living donor (n = 52) and (ii) deceased donor (n = 120). Seventy-four percent of the women had ≥2 pregnancies; median follow-up time was 5 years. Death-censored allograft survival was significantly lower in the H2W group compared to the other two groups (p = 0.03). Three of four graft losses in the H2W group were due to rejection. 5-year patient survival in the H2W group was high and similar compared to the other living donor group (100 vs. 98%; p = 0.28). The incidence of (sub)clinical antibody-mediated rejection was higher in the H2W group (36 vs. 20 vs. 18%) (p = 0.10). The frequency of infections was similar among the three groups. No immunological parameter was predictive for rejection or graft loss in H2W transplantations. In conclusion, H2W transplantation is a valuable option, but associated with a higher risk for allograft loss due to rejection despite T cell-depleting induction. Further research is required for better risk prediction on an individual patient level.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça